Tanriverdi Taner, Uzan Mustafa, Sanus Galip Zihni, Baykara Onur, Is Merih, Ozkara Cigdem, Buyra Nur
Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Surg Neurol. 2006 Jan;65(1):7-10; discussion 10. doi: 10.1016/j.surneu.2005.05.024.
Interleukin (IL) 1 is a proinflammatory cytokine that has been identified as an important mediator of neurodegeneration induced by ischemia or traumatic brain injury. Accumulating evidence to date has suggested that the major cytokine contributing to neurodegeneration after head injury is IL-1beta rather than IL-1alpha; however, there is no sufficient data regarding IL-1alpha in literature, and there may be an association between IL1A gene polymorphism and outcome after head injury.
We performed a prospective clinical study and included a recruited series of 71 patients who had head injury and were admitted to our neurosurgical unit. Severity of initial injury was assessed by the Glasgow Coma Scale. Outcome at 6 months after injury was assessed by means of the Glasgow Outcome Score. Interleukin 1alpha genotypes were determined from blood samples by standard methods.
Of 40 patients with IL1A2, 18 (45%) had an unfavorable outcome (dead, vegetative state, or severe disability) compared with 7 (22.5%) of 31 without IL1A2 (P = .08).
Our findings show that there is no genetic association between IL1A gene polymorphism and outcome after head injury. Further clinical studies should be designed to confirm and further evaluate these findings.
白细胞介素(IL)-1是一种促炎细胞因子,已被确定为缺血或创伤性脑损伤所致神经退行性变的重要介质。迄今为止,越来越多的证据表明,颅脑损伤后导致神经退行性变的主要细胞因子是IL-1β而非IL-1α;然而,文献中关于IL-1α的数据并不充分,且IL1A基因多态性与颅脑损伤后的预后之间可能存在关联。
我们进行了一项前瞻性临床研究,纳入了71例颅脑损伤并入住我院神经外科的患者。初始损伤的严重程度通过格拉斯哥昏迷量表进行评估。损伤后6个月的预后通过格拉斯哥预后评分进行评估。采用标准方法从血样中确定白细胞介素1α基因型。
40例携带IL1A2的患者中,18例(45%)预后不良(死亡、植物状态或严重残疾),而31例未携带IL1A2的患者中这一比例为7例(22.5%)(P = 0.08)。
我们的研究结果表明,IL1A基因多态性与颅脑损伤后的预后之间不存在遗传关联。应设计进一步的临床研究以证实并进一步评估这些发现。